Stock RAPT RAPT THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts RAPT Therapeutics, Inc.

Equities

RAPT

US75382E1091

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
8.1 USD +3.85% Intraday chart for RAPT Therapeutics, Inc. +1.89% -67.40%
Apr. 09 RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients CI
Mar. 27 JPMorgan Lowers RAPT Therapeutics' Price Target to $13 From $15, Keeps Neutral Rating MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 8.680 13.61 13.88
Spread/Res.-6.68%-40.48%-41.64%
Spread/Supp.+3.85%+17.90%+2.53%
Support 7.800 6.870 7.900

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. RAPT Stock
  4. Charts RAPT Therapeutics, Inc.